Clinical and biochemical polymorphism of spinal muscular atrophy
Objective: to conduct clinical laboratory studies of spinal muscular atrophy (SMA) for the clarification of the pathogenetic features and role of neurotrophic factors in the formation of polymorphism of this diseasePatients and methods. Thirty-five patients aged 9 months to 53 years (mean age, 14.5...
Main Authors: | M. G. Sokolova, S. V. Lobzin, I. V. Litvinenko, M. V. Rezvantsev, L. A. Polyakova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2017-03-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/697 |
Similar Items
-
Rehabilitation in spinal muscular atrophy
by: Joanna Iłżecka
Published: (2021-05-01) -
Spinal Muscular Atrophy
by: J Gordon Millichap
Published: (1990-02-01) -
Spinal Muscular Atrophy With Myoclonic Epilepsy
by: Buket ÖZKARA, et al.
Published: (2017-04-01) -
Oral risdiplam for specific therapy in adult patients with 5q spinal muscular atrophy in the Moscow region
by: Ekaterina S. Novikova
Published: (2023-09-01) -
Experience of Nusinersen in children with proximal spinal muscular atrophy 5q in Moscow region
by: M. V. Panteleeva
Published: (2022-12-01)